Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 1.24B 1.06B 990M 906M 1.7B 118B 1.72B 11.7B 4.56B 59.37B 4.64B 4.54B 196B P/E 2026 *
-27x
P/E 2027 * -34.9x
Enterprise Value 1.28B 1.1B 1.03B 942M 1.77B 123B 1.79B 12.16B 4.74B 61.71B 4.82B 4.72B 204B EV / Sales 2026 *
6.07x
EV / Sales 2027 * 5.47x
Free-Float
41.79%
Yield 2026 *
-
Yield 2027 * -
1 day+4.22%
1 week+49.48%
Current month+31.51%
1 month+23.61%
3 months+95.03%
6 months+178.71%
Current year+165.85%
1 week 5.53
Extreme 5.53
8.87
1 month 5.41
Extreme 5.41
8.87
Current year 2.8
Extreme 2.8
8.87
1 year 2.28
Extreme 2.28
8.87
3 years 1.66
Extreme 1.665
11.56
5 years 1.66
Extreme 1.665
63.55
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
8/10/26 Tax

Chief Executive Officer

-29,250 0.0198%
7/30/26 Tax

Chief Financial Officer

-5,465 0.0037%
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
Change 5-day change 1-year change 3-year change Capi.($)
+4.22%+49.48%+251.22%-14.54% 1.24B
-7.79%+27.15%+227.67%+36.57% 4.07B
+2.16%+6.26%+111.39%+317.85% 4.06B
+1.24%-0.68%+43.47%+70.67% 3.36B
-3.61%+0.62%-18.15%-21.90% 2.5B
+3.45%+2.60%+299.42%+478.00% 2.43B
+2.22%+16.37%+27.81% - 1.52B
-2.40%-4.39%+14.23%+45.93% 1.02B
-2.72%-3.01%-35.62%-3.73% 567M
-3.35%+11.04%+16.89%+258.18% 553M
Average -0.82%+8.38%+93.83%+129.67% 2.13B
Weighted average by Cap. -0.76%+11.36%+120.26%+149.19%

Financials

2026 *2027 *
Net sales 212M 181M 170M 155M 291M 20.24B 295M 2B 781M 10.17B 794M 777M 33.64B 226M 193M 181M 166M 311M 21.6B 315M 2.14B 834M 10.85B 848M 829M 35.89B
Net income -48.85M -41.85M -39.15M -35.84M -67.26M -4.67B -68.15M -463M -180M -2.35B -183M -179M -7.77B -33.6M -28.78M -26.93M -24.65M -46.26M -3.21B -46.87M -318M -124M -1.61B -126M -123M -5.34B
Net Debt 48.8M 41.8M 39.11M 35.8M 67.19M 4.67B 68.08M 462M 180M 2.35B 183M 179M 7.76B -385K -330K -309K -283K -530K -36.86M -537K -3.65M -1.42M -18.52M -1.45M -1.42M -61.25M
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
415
Date Price Change Volume
26-08-21 US$8.640 +4.22% 9,390,744
26-08-20 US$8.290 +14.82% 13,145,898
26-08-19 US$7.220 +25.78% 15,140,362
26-08-18 US$5.740 +1.06% 1,715,706
26-08-17 US$5.680 -0.35% 2,150,059
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
8.290USD
Average target price
7.300USD
Spread / Average Target
-11.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock